Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04248244 · ClinicalTrials.gov registry record · NA
Effects of Early Palliative Care Integration on Patients With Newly Diagnosed Multiple Myeloma
A NA study, sponsored by Case Comprehensive Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT04248244 is a NA study that has completed, run by Case Comprehensive Cancer Center. The registered enrollment target is 20 participants.
The verdict
NCT04248244, a NA study, has completed, sponsored by Case Comprehensive Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
Multiple Myeloma (MM) is a common type of cancer involving the cells in the blood (commonly affecting bones, kidneys and blood). Although it remains incurable, MM has become a highly treatable form cancer thanks to new and improved treatment modalities. As patients deal with this disease, they often suffer from multiple symptoms that are caused by both the disease itself and the different drugs used to treat it. Research has shown that the most common symptoms patients suffer from include pain, constipation, tiredness, tingling in hands and feet, breathlessness, sadness and difficulty remembering things. These symptoms may negatively affect the quality of life of patients. Palliative care (PC) is a type of treatment aimed at relieving symptoms and promoting the most optimal quality of life (QOL) for patients and their caregivers. Research has shown that patients with certain types of cancers, such as colon cancer and lung cancer, do better if they are seen by a PC provider early in the course of their disease. This study seeks to determine the effects of early PC involvement on participants with newly diagnosed MM
Interventions
- OTHER Palliative Care
- OTHER FACT-MM questionnaire
- OTHER HADS questionnaire
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2020-02-17 |
| Est. Completion | 2022-10-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04248244
The ClinicalTrials.gov registry entry for NCT04248244 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Case Comprehensive Cancer Center, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Palliative Care is the first listed.
NCT04248244 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04248244 about?
NCT04248244 is a clinical study titled "Effects of Early Palliative Care Integration on Patients With Newly Diagnosed Multiple Myeloma". Multiple Myeloma (MM) is a common type of cancer involving the cells in the blood (commonly affecting bones, kidneys and blood). Although it remains incurable, MM has become a highly treatable form cancer thanks to new and improved treatment modalities. As patients deal with this disease, they often...
What is the current status of trial NCT04248244?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2020-02-17. Estimated completion is 2022-10-26.
What interventions are being tested in trial NCT04248244?
The interventions under investigation include: Palliative Care (OTHER), FACT-MM questionnaire (OTHER), HADS questionnaire (OTHER).
Who is sponsoring clinical trial NCT04248244?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.